Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jiawen Qian"'
Autor:
Yuedi Wang, Yiyuan Gao, Congyi Niu, Bo Wang, Shushu Zhao, Gils Roex, Jiawen Qian, Jingbo Qie, Lin Chen, Chenhe Yi, Sébastien Anguille, Jie Liu, Feifei Luo, Yiwei Chu
Publikováno v:
Cancer immunology and immunotherapy
Chimeric antigen receptor (CAR) T-cell therapy achieves great success for hematological malignancies. However, clinical trials have revealed some limitations in both improving the efficacy and reducing the relapse, which calls for innovative strategi
Autor:
Zhiqiang Wang, Zhou Lu, Shengli Lin, Jie Xia, Ziwen Zhong, Zhangjuan Xie, Yun Xing, Jingbo Qie, Mengxia Jiao, Yifan Li, Haoyu Wen, Pengyuan Zhao, Dan Zhang, Pinghong Zhou, Jiawen Qian, Feifei Luo, Luman Wang, Hongxiu Yu, Jie Liu, Jie Gu, Ronghua Liu, Yiwei Chu
Publikováno v:
Immunity. 55:1067-1081.e8
Immunoregulatory B cells impede antitumor immunity through unknown features and mechanisms. We report the existence of leucine-tRNA-synthase-2 (LARS2)-expressing B cell (LARS B) subset with a transforming growth factor-β1 (TGF-β1)-dominant regulato
Autor:
Yiwei Chu, Jiawen Qian, Yanqing Wang, Jun Liu, Lumin Zhang, Hiromi Kubagawa, Ji-Yang Wang, Takeshi Tsubata, Ermeng Xiong, Hanying Zhu
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 9 (2018)
Frontiers in Immunology, Vol 9 (2018)
The marginal zone B cells (MZB) are located at the interface between the circulation and lymphoid tissue and as a gatekeeper play important roles in both innate and adaptive immune responses. We have previously found that MZB are significantly reduce
Autor:
Yiwei Yu, Dan Zhang, Xiujuan Zheng, Yiwei Chu, Wen Zhang, Wei Li, Yan Wang, Yi Feng, Naiqing Zhao, Jiawen Qian, Tian-shu Liu, Feifei Luo, Jiao Yang
Publikováno v:
International Immunopharmacology. 26:322-327
The XELOX regimen (capecitabine plus oxaliplatin) has been demonstrated as first-line chemotherapy for gastric cancer in China. However, the efficacy of XELOX varies in individuals. Some evidences indicate that the variable efficacy might be related
Publikováno v:
Clinical Immunology. 154:26-36
Adoptive immunotherapy is an attractive strategy for glioma treatment. However, some obstacles still need be overcome. In this study, GL261-bearing mice treated with adoptively transferred antigen-specific T cells and systemic injection of bacterial